Remove 2023 Remove Hospice Remove In-home health
article thumbnail

Enhabit’s 2023 M&A Strategy Leans Toward Hospice Assets

Hospice News

s (NYSE: EHAB) M&A journey has narrowed towards hospice, diverting less in home health’s direction. Reimbursement uncertainties, shrinking pools of available assets, and rising valuations in the home health space are forces steering the company’s sights towards hospice, according to Enhabit executives.

2023 229
article thumbnail

Amedisys Sees Hospice Admissions Dip Despite Revenue Growth

Hospice News

s (Nasdaq: AMED) hospice segment has seen headwinds impact admissions growth as the company awaits its pending acquisition by the UnitedHealth Group (NYSE: UNH) subsidiary Optum. The company’s hospice segment revenue reached $207.9 Gross margin for the hospice segment fell slightly to 42.9% Amedisys Inc.’s year-over-year.

Hospice 274
professionals

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

NAHC President Dombi: Hospices Face Stricter Oversight in 2023

Hospice News

Regulators have been keeping an increasingly close watch on hospice providers, and this may intensify in 2023. Moving into next year, hospices have a spectrum of crucial issues on their plates. Hospice will have a lot going on in the regulatory space next year. What are your expectations going into 2023?

2023 236
article thumbnail

Fallout of 2023 Home Health Payment Rule Likely to Affect Hospices

Hospice News

While home health operators brace for the impact of the meager 2023 reimbursement rates, hospices likewise must prepare for a ripple effect. base rate payment increase for home health care in 2023. In addition, the 2023 increase is only a temporary abatement.

2023 238
article thumbnail

How the 2023 Home Health Rule Could Change the Game in Hospice M&A

Hospice News

The pendulum of investor interest has swung hard into the hospice market in recent years, but shifts in reimbursement could steer buyers towards home health. Uncertainty earlier this year around Medicare’s proposed 2023 home health payment rates led some stakeholders to expect a swerve towards hospice.

2023 186
article thumbnail

M&A Volume May Shift From Hospice to Home Health

Hospice News

Though many expect a hospice M&A rebound in 2024, the scales are tipping in favor of home health companies among buyers. After 2023’s slump, PE firms have been sitting on more than $800 million in dry powder, according to data shared with Hospice News by The Braff Group. Interest rates remain a wild card.

Hospice 281
article thumbnail

2025 Could See Uptick in Hospice M&A, Less ‘Deal Fatigue’

Hospice News

Hospice transactions are facing a new world of challenges during a time when M&A activity is projected to ramp up after recent lulls. More founders who began their organizations when the Medicare Hospice Benefit was established in the 1980s are reaching retirement. Who’s going to receive the proceeds?

2025 285